Source: Dallas Citybizlist

Novelion Therapeutics: Mati Therapeutics Announces Purchase of Rights From Novelion Therapeutics

Read full article »
Novelion Therapeutics's Competitors | Novelion Therapeutics's News | Novelion Therapeutics's Financials
Stay up-to-date with the latest news on Novelion Therapeutics
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Benjamin Harshbarger's photo - Interim-CEO of Novelion Therapeutics

Interim-CEO

Benjamin Harshbarger

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on Novelion Therapeutics